Susquehanna International Group
NBRV

Susquehanna International Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Susquehanna International Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-608
Closed -$6K – 14619
2022
Q1 		$6K Sell
608
-664
-52% -$8.07K ﹤0.01% 12813
2021
Q4 		$19K Sell
1,272
-640
-33% -$15.2K ﹤0.01% 12841
2021
Q3 		$57K Sell
1,912
-1,412
-42% -$39.9K ﹤0.01% 12311
2021
Q2 		$112K Sell
3,324
-3,568
-52% -$133K ﹤0.01% 12038
2021
Q1 		$286K Buy
6,892
+4,520
+191% +$281K ﹤0.01% 10714
2020
Q4 		$144K Buy
2,372
+2,231
+1,582% +$242K ﹤0.01% 10275
2020
Q3 		$19K Buy
+141
New +$23.6K ﹤0.01% 10382
2020
Q2 		– Sell
-51
Closed -$7K – 11370
2020
Q1 		$7K Sell
51
-56
-52% -$17.1K ﹤0.01% 10086
2019
Q4 		$35K Sell
107
-64
-37% -$29.4K ﹤0.01% 9417
2019
Q3 		$86K Sell
171
-5
-3% -$2.82K ﹤0.01% 9628
2019
Q2 		$107K Buy
+176
New +$108K ﹤0.01% 9576
2018
Q4 		– Sell
-153
Closed -$103K – 10404
2018
Q3 		$103K Buy
153
+51
+50% +$36.1K ﹤0.01% 8599
2018
Q2 		$89K Buy
102
+20
+24% +$22.9K ﹤0.01% 9085
2018
Q1 		$103K Buy
+82
New +$121K ﹤0.01% 8692

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's NBRV Position: Q1 2023 in Review

Susquehanna International Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2023, closing a stake of 22,294 shares — an estimated $41K sold.

Susquehanna International Group first reported a position in NBRV in Q4 2017 and held it in 17 quarters. The position peaked at $1.11M in Q2 2019. 12 funds tracked by Wall St. Rank hold NBRV as of Q1 2023.

  • Susquehanna International Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 22,294 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2023, an estimated $41K.
  • Susquehanna International Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2017 and held it in 17 quarters.
  • Susquehanna International Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1.11M in Q2 2019.
  • 12 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.